Diebold Nixdorf Incorporated (DBD): Price and Financial Metrics
Diebold Nixdorf Incorporated (DBD)
Today's Latest Price: $3.85 USD
Updated Mar 27 12:00am
Add DBD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 134 in Financial Services (Enterprise)
See all "A" rated Strong Buy stocks
DBD Stock Summary
- DIEBOLD NIXDORF Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 2% of US listed stocks.
- DBD's price/sales ratio is 0.07; that's higher than the P/S ratio of merely 4.64% of US stocks.
- DBD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 1.84% of US stocks.
- If you're looking for stocks that are quantitatively similar to DIEBOLD NIXDORF Inc, a group of peers worth examining would be RST, UIS, NH, LTRE, and COE.
- Visit DBD's SEC page to see the company's official filings. To visit the company's web site, go to www.dieboldnixdorf.com.
DBD Stock Price Chart More Charts
DBD Price/Volume Stats
| Current price | $3.85 | 52-week high | $14.66 |
| Prev. close | $4.46 | 52-week low | $3.50 |
| Day low | $3.60 | Volume | 2,917,000 |
| Day high | $4.17 | Avg. volume | 1,742,435 |
| 50-day MA | $7.98 | Dividend yield | N/A |
| 200-day MA | $9.76 | Market Cap | 298.34M |
Diebold Nixdorf Incorporated (DBD) Company Bio
Diebold Nixdorf Inc. provides financial self-service delivery, integrated services and software, and security systems primarily to the financial, commercial, retail, and other markets. The company was founded in 1859 and is based in North Canton, Ohio.
DBD Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $3.85 | $2.98 | -33% |
Below please find a table outlining a discounted cash flow forecast for DBD, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that DIEBOLD NIXDORF Inc ranked in the 31th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for DIEBOLD NIXDORF Inc ended up being:
- The compound growth rate in the free cash flow of DIEBOLD NIXDORF Inc over the past 5.82 years is 0%; that's better than just 20.55% of cash flow producing equities in the Technology sector, where it is classified.
- 13% of the company's capital comes from equity, which is greater than just 6.55% of stocks in our cash flow based forecasting set.
- DIEBOLD NIXDORF Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.11. This coverage rate is greater than that of only 17.58% of stocks we're observing for the purpose of forecasting via discounted cash flows.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -35% |
| 1% | -34% |
| 2% | -33% |
| 3% | -33% |
| 4% | -32% |
| 5% | -31% |
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as DBD, try COHR, ORCL, MTSC, WK, and G.
Loading social stream, please wait...